What makes Tasly a great company to invest in?
If you’re interested in shaping the future of Western medicine by improving the quality of life for…
Update
15
Mar 19
11
Jan 19
Cardiovascular (T89) Drug Updates
Tests show it can reduce chronic stable angina. Tasly Pharmaceuticals Inc(Tasly US), is nearing the…
18
Sep 18
Tasly in Cooperation with Arbor on T89 R&D and Marketing
Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Arbor Phar…
Highlights
Cardiovascular (T89) Drug Clinical Studies
Dantonic® is a modernized and industrialized botanical drug formula of Danshen (Radix Salviae Miltiorrhizae, RSM) and Sanqi (Radix Notoginseng, RN) as active ingredients and Borneol as absorption enhancer. Dantonic® was approved as a prescription drug for the treatment of chronic stable angina pectoris in patients with coronary heart disease by the State Food and Drug Administration of China (CFDA) in 1993. Learn more.